Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a single drug replace chemo for some colon cancers?

NCT ID NCT05855200

Disease control Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests the immunotherapy drug dostarlimab against standard chemotherapy in 892 people with a specific type of colon cancer (dMMR/MSI-H) that has not spread. The goal is to see if dostarlimab alone can prevent cancer from coming back or causing death. Participants will receive either dostarlimab or standard chemo before and after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dostarlimab
What this could lead to
If successful, this could offer a chemotherapy-free option for certain colon cancers, potentially reducing side effects and improving outcomes.
What could go wrong
This is an early-phase trial, and results may not confirm benefit. Risks include immune-related side effects from dostarlimab, and it may not work for all participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 892 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

Mar 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Has untreated pathologically confirmed colon adenocarcinoma * Has resectable colon adenocarcinoma defined as clinically T4N0 or Stage III * Has radiologically evaluable disease * Has a tumor demonstrating the presence of either dMMR status or MSI-H Exclusion Criteria: * Has distant metastatic disease. * Has received prior medical therapy (chemotherapy, immunotherapy, biologic, or targeted therapy), radiation therapy or surgery for management of the current diagnosis of colon cancer * Has a tumor that, in the investigator's judgment is causing symptomatic bowel obstruction or otherwise requires urgent/emergent surgery at the time of screening. Participants with a history of colonic obstruction are eligible after obstruction is relieved by a diverting stoma (defunctioning ileostomy or colostomy). Patients with a history of colonic obstruction in the context of current colon cancer diagnosis and treated with colonic stents are not eligible. * Has undergone any major surgical procedure, open biopsy, or experienced significant traumatic injury within 28 days prior to randomization * Has any history of interstitial lung disease or pneumonitis and/or history of radiation induced enteritis. * Has cirrhosis or current unstable liver or biliary disease per investigator assessment defined by the presence of ascites, encephalopathy, coagulopathy, hypoalbuminemia, esophageal/gastric varices, or persistent jaundice * Has a history of allogenic stem cell transplantation or organ transplantation * Is receiving any other anticancer or experimental therapy. No other experimental therapies (including but not limited to chemotherapy, radiation, hormonal treatment, antibody therapy, immunotherapy, gene therapy, vaccine therapy, or other experimental drugs) of any kind are permitted while the participant is receiving study intervention * Is pregnant, breastfeeding, or expecting to conceive children within the projected duration of the study * Has a history of severe allergic and/or anaphylactic reactions to chimeric, human or humanized antibodies, fusion proteins, or known allergies to dostarlimab, or its excipients, or any components of FOLFOX or CAPEOX

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colon adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colon adenocarcinoma colonic neoplasm colorectal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colonic neoplasms Neoplasms, colon

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    229 sites in 27 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • GSK Investigational Site

    RECRUITING

    Tucson, Arizona, 85715, United States

  • GSK Investigational Site

    RECRUITING

    Los Angeles, California, 90027, United States

  • GSK Investigational Site

    RECRUITING

    New Haven, Connecticut, 06520, United States

  • GSK Investigational Site

    WITHDRAWN

    Washington D.C., District of Columbia, 20010, United States

  • GSK Investigational Site

    WITHDRAWN

    Deerfield Beach, Florida, 33064, United States

  • GSK Investigational Site

    WITHDRAWN

    Fort Lauderdale, Florida, 33316, United States

  • GSK Investigational Site

    WITHDRAWN

    Marietta, Georgia, 30060, United States

  • GSK Investigational Site

    RECRUITING

    Chicago, Illinois, 60611, United States

  • GSK Investigational Site

    RECRUITING

    Chicago, Illinois, 60612, United States

  • GSK Investigational Site

    WITHDRAWN

    Chicago, Illinois, 60637, United States

  • GSK Investigational Site

    RECRUITING

    Naperville, Illinois, 60126, United States

  • GSK Investigational Site

    RECRUITING

    Naperville, Illinois, 60540, United States

  • GSK Investigational Site

    RECRUITING

    Westwood, Kansas, 66205, United States

  • GSK Investigational Site

    WITHDRAWN

    Lexington, Kentucky, 40503, United States

  • GSK Investigational Site

    WITHDRAWN

    Louisville, Kentucky, 40206, United States

  • GSK Investigational Site

    WITHDRAWN

    Baton Rouge, Louisiana, 70809, United States

  • GSK Investigational Site

    RECRUITING

    Bethesda, Maryland, 20817, United States

  • GSK Investigational Site

    WITHDRAWN

    Ann Arbor, Michigan, 48109, United States

  • GSK Investigational Site

    RECRUITING

    Detroit, Michigan, 48202, United States

  • GSK Investigational Site

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

  • GSK Investigational Site

    WITHDRAWN

    Joplin, Missouri, 64804, United States

  • GSK Investigational Site

    WITHDRAWN

    St Louis, Missouri, 63128, United States

  • GSK Investigational Site

    WITHDRAWN

    St Louis, Missouri, 63141, United States

  • GSK Investigational Site

    RECRUITING

    Grand Island, Nebraska, 68803, United States

  • GSK Investigational Site

    RECRUITING

    Omaha, Nebraska, 68130, United States

  • GSK Investigational Site

    WITHDRAWN

    Omaha, Nebraska, 68198, United States

  • GSK Investigational Site

    WITHDRAWN

    Lebanon, New Hampshire, 03756, United States

  • GSK Investigational Site

    RECRUITING

    New York, New York, 10028, United States

  • GSK Investigational Site

    RECRUITING

    New York, New York, 10469, United States

  • GSK Investigational Site

    RECRUITING

    New York, New York, 11042, United States

  • GSK Investigational Site

    RECRUITING

    New York, New York, 11967, United States

  • GSK Investigational Site

    RECRUITING

    The Bronx, New York, 10461, United States

  • GSK Investigational Site

    RECRUITING

    Durham, North Carolina, 27710, United States

  • GSK Investigational Site

    RECRUITING

    Akron, Ohio, 44304, United States

  • GSK Investigational Site

    RECRUITING

    Cincinnati, Ohio, 45220, United States

  • GSK Investigational Site

    WITHDRAWN

    Cleveland, Ohio, 44111, United States

  • GSK Investigational Site

    WITHDRAWN

    Cleveland, Ohio, 44142, United States

  • GSK Investigational Site

    WITHDRAWN

    Cleveland, Ohio, 44196, United States

  • GSK Investigational Site

    WITHDRAWN

    Oklahoma City, Oklahoma, 73104, United States

  • GSK Investigational Site

    WITHDRAWN

    Oklahoma City, Oklahoma, 73120, United States

  • GSK Investigational Site

    WITHDRAWN

    Pittsburgh, Pennsylvania, 15212, United States

  • GSK Investigational Site

    RECRUITING

    Sioux Falls, South Dakota, 57078, United States

  • GSK Investigational Site

    RECRUITING

    Sioux Falls, South Dakota, 57105, United States

  • GSK Investigational Site

    RECRUITING

    Sioux Falls, South Dakota, 57401, United States

  • GSK Investigational Site

    RECRUITING

    Sioux Falls, South Dakota, 57501, United States

  • GSK Investigational Site

    WITHDRAWN

    Dallas, Texas, 75235, United States

  • GSK Investigational Site

    COMPLETED

    Dallas, Texas, 75390, United States

  • GSK Investigational Site

    RECRUITING

    Richmond, Virginia, 23229, United States

  • GSK Investigational Site

    RECRUITING

    Appleton, Wisconsin, 54911, United States

  • GSK Investigational Site

    RECRUITING

    Buenos Aires, 1093, Argentina

  • GSK Investigational Site

    RECRUITING

    Buenos Aires, C1180AAX, Argentina

  • GSK Investigational Site

    RECRUITING

    Buenos Aires, C1181ACH, Argentina

  • GSK Investigational Site

    RECRUITING

    Capital Federal, C1426ANZ, Argentina

  • GSK Investigational Site

    COMPLETED

    Ciudad Autonoma de Buenos Aire, C1431FWO, Argentina

  • GSK Investigational Site

    RECRUITING

    Córdoba, 5000, Argentina

  • GSK Investigational Site

    RECRUITING

    Mar del Plata, 7600, Argentina

  • GSK Investigational Site

    RECRUITING

    Rosario, S2002, Argentina

  • GSK Investigational Site

    RECRUITING

    San Miguel de Tucumán, T4000IHE, Argentina

  • GSK Investigational Site

    RECRUITING

    Santa Fe, S3000FUJ, Argentina

  • GSK Investigational Site

    RECRUITING

    Newcastle, New South Wales, 2298, Australia

  • GSK Investigational Site

    WITHDRAWN

    St Leonards, New South Wales, 2065, Australia

  • GSK Investigational Site

    RECRUITING

    Woolangabba, Queensland, 4102, Australia

  • GSK Investigational Site

    RECRUITING

    Heidelberg, Victoria, 3084, Australia

  • GSK Investigational Site

    WITHDRAWN

    Melbourne, Victoria, 3004, Australia

  • GSK Investigational Site

    RECRUITING

    Aalst, 9300, Belgium

  • GSK Investigational Site

    RECRUITING

    Brussels, 1070, Belgium

  • GSK Investigational Site

    RECRUITING

    Brussels, 1200, Belgium

  • GSK Investigational Site

    RECRUITING

    Edegem, 2650, Belgium

  • GSK Investigational Site

    RECRUITING

    Ghent, 9000, Belgium

  • GSK Investigational Site

    RECRUITING

    Leuven, 3000, Belgium

  • GSK Investigational Site

    RECRUITING

    Liège, 4000, Belgium

  • GSK Investigational Site

    RECRUITING

    Roeselare, 8800, Belgium

  • GSK Investigational Site

    RECRUITING

    Barretos, 14784-400, Brazil

  • GSK Investigational Site

    RECRUITING

    Belém, 66.073-005, Brazil

  • GSK Investigational Site

    RECRUITING

    Campo Grande, 79002-061, Brazil

  • GSK Investigational Site

    RECRUITING

    Lages, 88501-001, Brazil

  • GSK Investigational Site

    RECRUITING

    Natal, 59075-740, Brazil

  • GSK Investigational Site

    RECRUITING

    Porto Alegre, 90610-000, Brazil

  • GSK Investigational Site

    RECRUITING

    Salvador, 40414-120, Brazil

  • GSK Investigational Site

    RECRUITING

    São José do Rio Preto, 15090-000, Brazil

  • GSK Investigational Site

    RECRUITING

    São Paulo, 01509-010, Brazil

  • GSK Investigational Site

    RECRUITING

    São Paulo, 04312903, Brazil

  • GSK Investigational Site

    RECRUITING

    Teresina, 64049-200, Brazil

  • GSK Investigational Site

    RECRUITING

    Vitória, 29043-260, Brazil

  • GSK Investigational Site

    WITHDRAWN

    Edmonton, Alberta, T6G 1Z2, Canada

  • GSK Investigational Site

    RECRUITING

    Halifax, Nova Scotia, B3H 1V7, Canada

  • GSK Investigational Site

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

  • GSK Investigational Site

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • GSK Investigational Site

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • GSK Investigational Site

    RECRUITING

    Beijing, 100036, China

  • GSK Investigational Site

    RECRUITING

    Beijing, 100083, China

  • GSK Investigational Site

    RECRUITING

    Beijing, 100730, China

  • GSK Investigational Site

    RECRUITING

    Changchun, 130021, China

  • GSK Investigational Site

    RECRUITING

    Changsha, 410013, China

  • GSK Investigational Site

    RECRUITING

    Chengdu, 610041, China

  • GSK Investigational Site

    RECRUITING

    Chongqing, 400042, China

  • GSK Investigational Site

    RECRUITING

    Chongqing, 400042, China

  • GSK Investigational Site

    RECRUITING

    Guangzhou, 510060, China

  • GSK Investigational Site

    RECRUITING

    Guangzhou, 510655, China

  • GSK Investigational Site

    RECRUITING

    Hangzhou, 310016, China

  • GSK Investigational Site

    RECRUITING

    Hangzhou, 310022, China

  • GSK Investigational Site

    RECRUITING

    Hangzhou, 311100, China

  • GSK Investigational Site

    RECRUITING

    Hangzhou, China

  • GSK Investigational Site

    RECRUITING

    Harbin, 150000, China

  • GSK Investigational Site

    RECRUITING

    Jinan, 250117, China

  • GSK Investigational Site

    RECRUITING

    Kunming, 650106, China

  • GSK Investigational Site

    RECRUITING

    Meizhou, 514700, China

  • GSK Investigational Site

    RECRUITING

    Nanchang, 330006, China

  • GSK Investigational Site

    RECRUITING

    Nanchang, 330029, China

  • GSK Investigational Site

    RECRUITING

    Shanghai, 200032, China

  • GSK Investigational Site

    RECRUITING

    Shanghai, 200032, China

  • GSK Investigational Site

    RECRUITING

    Shenzhen, 518036, China

  • GSK Investigational Site

    RECRUITING

    Taiyuan, 030013, China

  • GSK Investigational Site

    RECRUITING

    Tianjin, 300000, China

  • GSK Investigational Site

    RECRUITING

    Wuhan, 430030, China

  • GSK Investigational Site

    RECRUITING

    Xiamen, 361004, China

  • GSK Investigational Site

    RECRUITING

    Yangzhou, 225001, China

  • GSK Investigational Site

    RECRUITING

    Zhengzhou, 450052, China

  • GSK Investigational Site

    RECRUITING

    Hradec Králové, 500 05, Czechia

  • GSK Investigational Site

    RECRUITING

    Nový Jičín, 741 01, Czechia

  • GSK Investigational Site

    RECRUITING

    Prague, 150 06, Czechia

  • GSK Investigational Site

    RECRUITING

    Tallinn, 11312, Estonia

  • GSK Investigational Site

    RECRUITING

    Tallinn, 13419, Estonia

  • GSK Investigational Site

    RECRUITING

    Tartu, 50501, Estonia

  • GSK Investigational Site

    RECRUITING

    Helsinki, 00029, Finland

  • GSK Investigational Site

    RECRUITING

    Tampere, 33520, Finland

  • GSK Investigational Site

    RECRUITING

    Turku, 20521, Finland

  • GSK Investigational Site

    RECRUITING

    Lyon, 69008, France

  • GSK Investigational Site

    RECRUITING

    Marseille, 13385, France

  • GSK Investigational Site

    RECRUITING

    Nantes, 44093, France

  • GSK Investigational Site

    RECRUITING

    Paris, 75015, France

  • GSK Investigational Site

    RECRUITING

    Pessac, 33604, France

  • GSK Investigational Site

    RECRUITING

    Rennes, 35042, France

  • GSK Investigational Site

    COMPLETED

    Rouen, 76000, France

  • GSK Investigational Site

    RECRUITING

    Saint-Priest-en-Jarez, 42270, France

  • GSK Investigational Site

    RECRUITING

    Suresnes, 92150, France

  • GSK Investigational Site

    RECRUITING

    Toulouse, 31059, France

  • GSK Investigational Site

    RECRUITING

    Villejuif, 94805, France

  • GSK Investigational Site

    RECRUITING

    Berlin, 13353, Germany

  • GSK Investigational Site

    RECRUITING

    Düsseldorf, 40225, Germany

  • GSK Investigational Site

    RECRUITING

    Frankfurt, 60488, Germany

  • GSK Investigational Site

    WITHDRAWN

    Halle, 06120, Germany

  • GSK Investigational Site

    RECRUITING

    Lübeck, 23562, Germany

  • GSK Investigational Site

    RECRUITING

    Mannheim, 68167, Germany

  • GSK Investigational Site

    RECRUITING

    München, 81377, Germany

  • GSK Investigational Site

    RECRUITING

    München, 81737, Germany

  • GSK Investigational Site

    COMPLETED

    Athens, 11528, Greece

  • GSK Investigational Site

    COMPLETED

    Thessaloniki, 54639, Greece

  • GSK Investigational Site

    COMPLETED

    Thessaloniki, 570 10, Greece

  • GSK Investigational Site

    RECRUITING

    Bengaluru, Karnataka, 560076, India

  • GSK Investigational Site

    RECRUITING

    Ludhiana, Punjab, 141123, India

  • GSK Investigational Site

    RECRUITING

    Belagavi, 590010, India

  • GSK Investigational Site

    RECRUITING

    Hyderabad, 500034, India

  • GSK Investigational Site

    RECRUITING

    Nashik, 422002, India

  • GSK Investigational Site

    RECRUITING

    Pune, 411040, India

  • GSK Investigational Site

    RECRUITING

    Cagliari, 09042, Italy

  • GSK Investigational Site

    RECRUITING

    Genova, 16132, Italy

  • GSK Investigational Site

    RECRUITING

    Milan, 20162, Italy

  • GSK Investigational Site

    RECRUITING

    Naples, 80131, Italy

  • GSK Investigational Site

    RECRUITING

    Padova, 35128, Italy

  • GSK Investigational Site

    RECRUITING

    Pisa, 56126, Italy

  • GSK Investigational Site

    RECRUITING

    Reggio Emilia, 40123, Italy

  • GSK Investigational Site

    RECRUITING

    Roma, 00152, Italy

  • GSK Investigational Site

    RECRUITING

    Roma, 00168, Italy

  • GSK Investigational Site

    RECRUITING

    Rozzano MI, 20089, Italy

  • GSK Investigational Site

    RECRUITING

    Aichi, 464-8681, Japan

  • GSK Investigational Site

    RECRUITING

    Chiba, 277-8577, Japan

  • GSK Investigational Site

    RECRUITING

    Fukuoka, 812-8582, Japan

  • GSK Investigational Site

    RECRUITING

    Hokkaido, 060-8648, Japan

  • GSK Investigational Site

    WITHDRAWN

    Hyōgo, 650-0047, Japan

  • GSK Investigational Site

    RECRUITING

    Ibaraki, 309-1793, Japan

  • GSK Investigational Site

    RECRUITING

    Kanagawa, 216-8511, Japan

  • GSK Investigational Site

    RECRUITING

    Kanagawa, 232-0024, Japan

  • GSK Investigational Site

    RECRUITING

    Kyoto, 606-8507, Japan

  • GSK Investigational Site

    RECRUITING

    Okayama, 710-8602, Japan

  • GSK Investigational Site

    RECRUITING

    Osaka, 540-0006, Japan

  • GSK Investigational Site

    RECRUITING

    Osaka, 541-8567, Japan

  • GSK Investigational Site

    RECRUITING

    Osaka, 558-8558, Japan

  • GSK Investigational Site

    RECRUITING

    Osaka, 565-0871, Japan

  • GSK Investigational Site

    RECRUITING

    Osaka, 573-1191, Japan

  • GSK Investigational Site

    RECRUITING

    Shizuoka, 411-8777, Japan

  • GSK Investigational Site

    RECRUITING

    Tokyo, 104-0045, Japan

  • GSK Investigational Site

    RECRUITING

    Tokyo, 135-8550, Japan

  • GSK Investigational Site

    RECRUITING

    DF, 14000, Mexico

  • GSK Investigational Site

    RECRUITING

    Guadalajara, 44280, Mexico

  • GSK Investigational Site

    COMPLETED

    Guadalajara, 44650, Mexico

  • GSK Investigational Site

    RECRUITING

    Mexico City, 03100, Mexico

  • GSK Investigational Site

    RECRUITING

    Oaxaca City, 68020, Mexico

  • GSK Investigational Site

    COMPLETED

    San Pedro Garza García, 66220, Mexico

  • GSK Investigational Site

    RECRUITING

    Tijuana, 22010, Mexico

  • GSK Investigational Site

    RECRUITING

    Breda, 4818 CK, Netherlands

  • GSK Investigational Site

    RECRUITING

    Maastricht, 6229 HX, Netherlands

  • GSK Investigational Site

    RECRUITING

    Nijmegen, 6525 GA, Netherlands

  • GSK Investigational Site

    RECRUITING

    Utrecht, 3584 CX, Netherlands

  • GSK Investigational Site

    RECRUITING

    Bergen, 5021, Norway

  • GSK Investigational Site

    RECRUITING

    Kristiansand, 4604, Norway

  • GSK Investigational Site

    RECRUITING

    Lrenskog, 1474, Norway

  • GSK Investigational Site

    RECRUITING

    Oslo, 0407, Norway

  • GSK Investigational Site

    RECRUITING

    Stavanger, 4011, Norway

  • GSK Investigational Site

    WITHDRAWN

    Tromsø, 9019, Norway

  • GSK Investigational Site

    RECRUITING

    Punta Pacifica Panama City Panama, Panama

  • GSK Investigational Site

    RECRUITING

    Bydgoszcz, 85-048, Poland

  • GSK Investigational Site

    RECRUITING

    Warsaw, 02-034, Poland

  • GSK Investigational Site

    RECRUITING

    Almada, 2805-267, Portugal

  • GSK Investigational Site

    RECRUITING

    Coimbra, 3000-075, Portugal

  • GSK Investigational Site

    RECRUITING

    Lisbon, 1649-035, Portugal

  • GSK Investigational Site

    RECRUITING

    Daegu, 41404, South Korea

  • GSK Investigational Site

    RECRUITING

    Gyeonggi-do, 463712, South Korea

  • GSK Investigational Site

    RECRUITING

    Seoul, 06351, South Korea

  • GSK Investigational Site

    RECRUITING

    Seoul, 06591, South Korea

  • GSK Investigational Site

    RECRUITING

    Seoul, 138-736, South Korea

  • GSK Investigational Site

    RECRUITING

    Badajoz, 06080, Spain

  • GSK Investigational Site

    RECRUITING

    BaracaldoVizcaya, 48903, Spain

  • GSK Investigational Site

    RECRUITING

    Barcelona, 08026, Spain

  • GSK Investigational Site

    RECRUITING

    Barcelona, 08035, Spain

  • GSK Investigational Site

    RECRUITING

    Barcelona, 08036, Spain

  • GSK Investigational Site

    RECRUITING

    Córdoba, 14004, Spain

  • GSK Investigational Site

    RECRUITING

    Donostia / San Sebastian, 20080, Spain

  • GSK Investigational Site

    RECRUITING

    Elche Alicante, 03203, Spain

  • GSK Investigational Site

    RECRUITING

    Granada, 18014, Spain

  • GSK Investigational Site

    RECRUITING

    Jaén, 23007, Spain

  • GSK Investigational Site

    RECRUITING

    L'Hospitalet de Llobrega, 08908, Spain

  • GSK Investigational Site

    RECRUITING

    Las Palmas de Gran Canar, 35016, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28006, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28009, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28034, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28040, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28040, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28041, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28046, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28050, Spain

  • GSK Investigational Site

    RECRUITING

    Madrid, 28222, Spain

  • GSK Investigational Site

    RECRUITING

    Málaga, 29010, Spain

  • GSK Investigational Site

    RECRUITING

    Oviedo, 33011, Spain

  • GSK Investigational Site

    RECRUITING

    Pamplona, 31008, Spain

  • GSK Investigational Site

    RECRUITING

    Santander, 39011, Spain

  • GSK Investigational Site

    RECRUITING

    Seville, 41013, Spain

  • GSK Investigational Site

    RECRUITING

    Valencia, 46009, Spain

  • GSK Investigational Site

    RECRUITING

    Valencia, 46010, Spain

  • GSK Investigational Site

    RECRUITING

    Valencia, 46014, Spain

  • GSK Investigational Site

    RECRUITING

    Zaragoza, 50009, Spain

  • GSK Investigational Site

    WITHDRAWN

    Eskilstuna, 63349, Sweden

  • GSK Investigational Site

    RECRUITING

    Gothenburg, SE-413 45, Sweden

  • GSK Investigational Site

    RECRUITING

    Linköping, SE-581 85, Sweden

  • GSK Investigational Site

    RECRUITING

    Malmö, 20502, Sweden

  • GSK Investigational Site

    WITHDRAWN

    Stockholm, 11219, Sweden

  • GSK Investigational Site

    RECRUITING

    Stockholm, 11883, Sweden

  • GSK Investigational Site

    RECRUITING

    Uppsala, SE-751 85, Sweden

  • GSK Investigational Site

    RECRUITING

    Kaohsiung City, 833, Taiwan

  • GSK Investigational Site

    RECRUITING

    Tainan, 704, Taiwan

  • GSK Investigational Site

    RECRUITING

    Taipei, 100, Taiwan

  • GSK Investigational Site

    RECRUITING

    Taoyuan, 333, Taiwan

  • GSK Investigational Site

    RECRUITING

    Ankara, 06010, Turkey (Türkiye)

  • GSK Investigational Site

    RECRUITING

    Ankara, 06230, Turkey (Türkiye)

  • GSK Investigational Site

    RECRUITING

    Ankara, Turkey (Türkiye)

  • GSK Investigational Site

    RECRUITING

    Istanbul, 34722, Turkey (Türkiye)

  • GSK Investigational Site

    RECRUITING

    Birmingham, B9 5SS, United Kingdom

  • GSK Investigational Site

    RECRUITING

    Chelmsford, CM1 7ET, United Kingdom

  • GSK Investigational Site

    RECRUITING

    Cheltenham, GL53 7AN, United Kingdom

  • GSK Investigational Site

    RECRUITING

    Edinburgh, EH4 2XU, United Kingdom

  • GSK Investigational Site

    RECRUITING

    Hull, HU16 5JQ, United Kingdom

  • GSK Investigational Site

    RECRUITING

    Leeds West Yorkshire, LS9 7TF, United Kingdom

  • GSK Investigational Site

    RECRUITING

    London, NW3 2QG, United Kingdom

  • GSK Investigational Site

    RECRUITING

    London, SW3 6JJ, United Kingdom

  • GSK Investigational Site

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • GSK Investigational Site

    RECRUITING

    Sutton, SM2 5PT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.